نتائج البحث - "Daniela Bartoletti"

51

دورية أكاديمية

Presentation and Outcome of 199 Patients with 2016 Who Diagnosis of Early and Overt Primary Myelofibrosis Treated with Ruxolitinib

المساهمون: Palandri, Francesca, Palumbo, Giuseppe A., Abruzzese, Elisabetta, Iurlo, Alessandra, Polverelli, Nicola, Bonifacio, Massimiliano, Bergamaschi, Micaela, Maria Elli, Elena, Benevolo, Giulia, Tieghi, Alessia, Sgherza, Nicola, Isidori, Alessandro, Binotto, Gianni, Crugnola, Monica, Bosi, Costanza, Cavazzini, Francesco, Latagliata, Roberto, Cattaneo, Daniele, Auteri, Giuseppe, Scaffidi, Luigi, Monika Trawinska, Malgorzata, Catani, Lucia, Robin, Foà, Vitolo, Umberto, Aversa, Franco, Massimo Lemoli, Roberto, Cuneo, Antonio, Krampera, Mauro, Semenzato, Gianpietro, DI RAIMONDO, Francesco, Cavo, Michele, Bartoletti, Daniela, Vianelli, Nicola, Breccia, Massimo

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000454842800216; volume:132; issue:1; journal:BLOOD; https://hdl.handle.net/11573/1685293Test

الإتاحة: https://doi.org/10.1182/blood-2018-99-116165Test
https://hdl.handle.net/11573/1685293Test

View record in BASE

52

Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms

المؤلفون: Flaminia Fanelli, Uberto Pagotto, Marina Martello, Michele Cavo, Giuseppe Auteri, Francesca Palandri, Daniela Bartoletti, Emanuela Ottaviani, Dorian Forte, Marco Mezzullo, Antonio Curti, Carolina Terragna, Martina Barone, Giulia Corradi, Lucia Catani

المساهمون: Forte D., Fanelli F., Mezzullo M., Barone M., Corradi G., Auteri G., Bartoletti D., Martello M., Ottaviani E., Terragna C., Curti A., Pagotto U., Palandri F., Cavo M., Catani L.

المصدر: International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 3399, p 3399 (2020)
Volume 21
Issue 9

مصطلحات موضوعية: Male, 0301 basic medicine, Metabolite, Myeloproliferative neoplasm, Oleic Acids, lcsh:Chemistry, chemistry.chemical_compound, 0302 clinical medicine, Polycythemia vera, Tandem Mass Spectrometry, Platelet, lcsh:QH301-705.5, Spectroscopy, Aged, 80 and over, essential thrombocythemia, Myelofibrosi, food and beverages, General Medicine, Middle Aged, Endocannabinoid system, Computer Science Applications, Haematopoiesis, Ethanolamines, 030220 oncology & carcinogenesis, Female, lipids (amino acids, peptides, and proteins), N-acylethanolamines, Thrombocythemia, Essential, Adult, medicine.medical_specialty, Polyunsaturated Alkamides, Mutation, Missense, myelofibrosis, Arachidonic Acids, Palmitic Acids, Article, myeloproliferative neoplasms, Catalysis, Glycerides, Inorganic Chemistry, 03 medical and health sciences, polycythemia vera, Internal medicine, medicine, Humans, endocannabinoids, Physical and Theoretical Chemistry, Myelofibrosis, Molecular Biology, Endocannabinoid, Aged, Myeloproliferative Disorders, Essential thrombocythemia, business.industry, Organic Chemistry, N-acylethanolamine, Cancer, Janus Kinase 2, medicine.disease, Amides, 030104 developmental biology, Endocrinology, lcsh:Biology (General), lcsh:QD1-999, chemistry, Primary Myelofibrosis, business, Chromatography, Liquid

وصف الملف: application/pdf; ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e12dae39875741cfe1000447213b746Test
https://doi.org/10.3390/ijms21093399Test

53

Impact of Comorbidities and Body Mass Index in Patients with Polycythemia Vera: A PV-NET Real World Study

المصدر: Blood. 134:4184-4184

مصطلحات موضوعية: Thrombotic risk, medicine.medical_specialty, business.industry, education, Immunology, Improved survival, Cell Biology, Hematology, Aggressive disease, medicine.disease, Blast Phase, Biochemistry, Polycythemia vera, Abnormal body mass index, Internal medicine, medicine, In patient, business, Body mass index

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::11c27a7ab1d5e564e19e85243e1614d3Test
https://doi.org/10.1182/blood-2019-125387Test

54

Risk Factors for Progression to Blast Phase and Outcome in 589 Patients with Myelofibrosis Treated with Ruxolitinib: Real-World Evidence

المصدر: Blood. 134:4166-4166

مصطلحات موضوعية: Ruxolitinib, medicine.medical_specialty, business.industry, Immunology, Salvage treatment, Cell Biology, Hematology, Real world evidence, Blast Phase, Biochemistry, Prognostic score, Internal medicine, Medicine, Treatment strategy, Electronic database, business, Median survival, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::812326ff08333b3631679baf45618774Test
https://doi.org/10.1182/blood-2019-123379Test

55

Clinical Outcomes Under Hydroxyurea and Impact of ELN Responses in Patients with Polycythemia Vera: A PV-NET Real World Study

المصدر: Blood. 134:4174-4174

مصطلحات موضوعية: Thrombotic risk, medicine.medical_specialty, business.industry, Immunology, Cell Biology, Hematology, medicine.disease, Blast Phase, Biochemistry, Outcome parameter, Palpable spleen, Polycythemia vera, Median time, Internal medicine, medicine, In patient, Skin lesion, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::bdb0f4cb4665e2501739735320cac20eTest
https://doi.org/10.1182/blood-2019-125388Test

56

Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study

المؤلفون: Costanza Bosi, Franco Aversa, Elisabetta Abruzzese, Nicola Vianelli, Giulia Benevolo, G. Semenzato, Bruno Martino, Daniele Cattaneo, Adalberto Ibatici, Nicola Polverelli, Daniela Bartoletti, Nicola Sgherza, Massimiliano Bonifacio, Roberto Latagliata, Francesca Palandri, Francesco Di Raimondo, Francesco Cavazzini, Micaela Bergamaschi, Michele Cavo, Massimo Breccia, Mariella D'Adda, Alessandra Iurlo, Alessandro Isidori, Maria Letizia Bacchi Reggiani, Giuseppe A. Palumbo, Luigi Scaffidi, Alessia Tieghi, Gianni Binotto, Antonio Cuneo, Monica Crugnola, Francesco Soci, Roberto M. Lemoli, Mario Tiribelli, Lucia Catani, Giuseppe Auteri, Malgorzata Monika Trawinska, Florian H. Heidel, Domenico Penna, Domenico Russo

المساهمون: Palandri F, Palumbo GA, Iurlo A, Polverelli N, Benevolo G, Breccia M, Abruzzese E, Tiribelli M, Bonifacio M, Tieghi A, Isidori A, Martino B, Sgherza N, D'Adda M, Bergamaschi M, Crugnola M, Cavazzini F, Bosi C, Binotto G, Auteri G, Latagliata R, Ibatici A, Scaffidi L, Penna D, Cattaneo D, Soci F, Trawinska M, Russo D, Cuneo A, Semenzato G, Di Raimondo F, Aversa F, Lemoli RM, Heidel F, Reggiani MLB, Bartoletti D, Cavo M, Catani L, Vianelli N.

مصطلحات موضوعية: Ruxolitinib, medicine.medical_specialty, Anemia, Socio-culturale, Myelofibrosis, Gastroenterology, MYSEC-PM, Efficacy, 03 medical and health sciences, Essential, 0302 clinical medicine, Polycythemia vera, Internal medicine, Nitriles, Risk scores, Humans, Medicine, Thrombocythemia, Polycythemia Vera, Survival rate, Janus Kinases, business.industry, Essential thrombocythemia, IPSS, Myelofibrosi, Hematology, Prognosis, medicine.disease, Primary Myelofibrosis, Pyrazoles, Survival Rate, Thrombocythemia, Essential, Pyrimidines, International Prognostic Scoring System, 030220 oncology & carcinogenesis, Risk score, business, IPSS, MYSEC-PM, Myelofibrosis, Risk scores, Ruxolitinib, 030215 immunology, medicine.drug